PAVmed (PAVMZ) Competitors $0.02 -0.02 (-61.96%) (As of 12:38 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends PAVMZ vs. DRTSW, ANZUW, BBLGW, BRSHW, GMVDW, HSCSW, BEATW, LUCYW, IINNW, and NXGLWShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), Inspira Technologies Oxy B.H.N. (IINNW), and NEXGEL (NXGLW). These companies are all part of the "medical equipment" industry. PAVmed vs. Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. NEXGEL Alpha Tau Medical (NASDAQ:DRTSW) and PAVmed (NASDAQ:PAVMZ) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, community ranking, media sentiment, earnings, analyst recommendations, risk, profitability and valuation. Which has stronger valuation & earnings, DRTSW or PAVMZ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/AN/AN/AN/APAVmed$3.83MN/AN/AN/AN/A Is DRTSW or PAVMZ more profitable? Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A N/A N/A PAVmed N/A N/A N/A Does the media favor DRTSW or PAVMZ? In the previous week, Alpha Tau Medical had 1 more articles in the media than PAVmed. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for PAVmed. Alpha Tau Medical's average media sentiment score of 0.00 equaled PAVmed'saverage media sentiment score. Company Overall Sentiment Alpha Tau Medical Neutral PAVmed Neutral Does the MarketBeat Community favor DRTSW or PAVMZ? Alpha Tau Medical and PAVmed both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAlpha Tau MedicalN/AN/APAVmedN/AN/A Do analysts recommend DRTSW or PAVMZ? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/APAVmed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryAlpha Tau Medical and PAVmed tied by winning 1 of the 2 factors compared between the two stocks. Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVMZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVMZ vs. The Competition Export to ExcelMetricPAVmedMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.79B$5.02B$8.44BDividend YieldN/A2.48%7.49%4.16%P/E RatioN/A195.22127.0816.62Price / SalesN/A191.531,683.1877.41Price / CashN/A15.5136.9033.53Price / BookN/A3.324.585.21Net IncomeN/A$66.48M$113.81M$223.74M7 Day PerformanceN/A-0.53%111.02%2.82%1 Month PerformanceN/A-2.71%125.11%8.93%1 Year PerformanceN/A37.84%155.23%29.44% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMZPAVmedN/A$0.02-62.0%N/AN/A$0.00$3.83M0.0090Gap DownDRTSWAlpha Tau MedicalN/A$0.19flatN/AN/A$0.00N/A0.0080News CoveragePositive NewsGap DownANZUWAnzu Special Acquisition Corp IN/A$0.06+20.0%N/A+501.9%$0.00N/A0.002Gap UpBBLGWBone BiologicsN/A$33.33+11.1%N/A+1,352.3%$0.00N/A0.002Gap UpBRSHWBruush Oral CareN/A$0.01flatN/AN/A$0.00$2.92M0.0011Gap UpGMVDWG Medical InnovationsN/A$0.02flatN/AN/A$0.00$4.42M0.0072Gap UpHSCSWHeart Test LaboratoriesN/A$0.04flatN/AN/A$0.00$18,600.000.0010Positive NewsBEATWHeartBeamN/A$0.75-2.6%N/AN/A$0.00N/A0.005High Trading VolumeLUCYWInnovative EyewearN/A$0.05-0.4%N/A-59.3%$0.00$1.53M0.009News CoveragePositive NewsGap DownIINNWInspira Technologies Oxy B.H.N.N/A$0.37flatN/A+192.9%$0.00N/A0.0020NXGLWNEXGELN/A$0.57+3.6%N/A+33.3%$0.00$5.01M0.0010Positive NewsGap Down Related Companies and Tools Related Companies Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives G Medical Innovations Alternatives Heart Test Laboratories Alternatives HeartBeam Alternatives Innovative Eyewear Alternatives Inspira Technologies Oxy B.H.N. Alternatives NEXGEL Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PAVMZ) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.